Dystrophic Epidermolysis Bullosa Clinical Trial
Official title:
Double Blind, Randomized, Phase II Clinical Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET Versus Vehicle Control in Dystrophic Epidermolysis Bullosa (DEB) Patients
After confirming eligibility, a single subject with four selected target lesions will receive both ALLO-ASC-SHEET and Vehicle control, three target lesions for ALLO-ASC-SHEET and the other target for Vehicle control, and which lesion to apply which IP treatment will be determined randomly at the time of enrollment using pre-designed block randomization scheme.
Primary efficacy endpoint will be assessed during and after 12th IP applications. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03536143 -
A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients
|
Phase 1/Phase 2 | |
Recruiting |
NCT04917887 -
Long-Term Follow-up Protocol
|
||
Completed |
NCT04917874 -
A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa
|
Phase 3 | |
Terminated |
NCT03578029 -
Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa
|
Phase 2 | |
Completed |
NCT03472287 -
To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)
|
Phase 1 | |
Withdrawn |
NCT01528306 -
A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
|
Phase 2 | |
Completed |
NCT02178969 -
Short Term Observational Study in DEB Patients
|
||
Withdrawn |
NCT04214002 -
The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)
|
||
Recruiting |
NCT04757727 -
Gynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)
|
||
Withdrawn |
NCT01768026 -
Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
|
N/A | |
Completed |
NCT01538862 -
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
|
N/A | |
Completed |
NCT03183934 -
A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial
|
||
Completed |
NCT02579369 -
Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02004600 -
Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB
|
N/A | |
Completed |
NCT04491604 -
Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB
|
Phase 3 | |
Not yet recruiting |
NCT05529134 -
Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04173650 -
MSC EVs in Dystrophic Epidermolysis Bullosa
|
Phase 1/Phase 2 |